Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Seminars in Liver Disease|April 13, 2019
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein ThrombosisEthan M Weinberg, Julia Palecki, K Rajender ReddySeminars in Liver Disease|May 6, 2021
Blinding in Clinical Trials for Chronic Liver DiseasesVivian Ortiz, Susan S Ellenberg, Ethan M WeinbergSeminars in Liver Disease|July 25, 2018
A Comprehensive Review of Hepatic SarcoidSasha Deutsch-Link, Danielle Fortuna, Ethan M WeinbergThe Journal of Infectious Diseases|February 8, 2013
Pathogenesis of accelerated fibrosis in HIV/HCV co-infectionWenyu Lin, Ethan M Weinberg, Raymond T ChungHepatology (Baltimore, Md.)|October 8, 2025
Hepatic sarcoid - A reviewEthan M Weinberg, Sevda Aghayeva, Rajender K ReddyHepatology Communications|June 5, 2024
Autoimmune hepatitis: Current and future therapiesNancy S Reau, Craig S Lammert, Ethan M WeinbergTransplantation|March 29, 2022
Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current EraTherese Bittermann, Nadim Mahmud, Ethan M Weinberg, et al.Digestive Diseases and Sciences|February 13, 2023
Clinical Predictors of Intensive Care Unit Transfer in Admitted Patients with CirrhosisMatthew Dukewich, Chung-Heng Liu, Ethan M Weinberg, et al.Journal of Vascular and Interventional Radiology : JVIR|August 20, 2021
Radiologically Placed Peritoneovenous Shunt is an Acceptable Treatment Alternative for Refractory Ascites Due to End-Stage Liver DiseaseMina Bakhtiar, Kimberly A Forde, Gregory J Nadolski, et al.Alimentary Pharmacology & Therapeutics|August 16, 2022
Autoimmune hepatitis and metabolic syndrome-associated disease development: a U.S. cohort studyMuhammad I Jalal, Mihir Brahmbhatt, Kelsey Green, et al.Pageof 5